33rd Annual Meeting

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 tweeters

patent: 16 patents

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 76 Mendeley

Summary Twitter Patents Dimensions citations

So far, Dimensions has found 45 publications that cite this research output.

45

The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.

Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death‐ligand 1 inhibitors in non–small cell lung cancer

Article in Cancer (February 2023)

Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis

Article in Cancers (December 2022)

Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy

Article in BioDrugs (December 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.